Normal locomotion of the nematode Caenorhabditis elegans requires transmission of contractile force from the myofibrillar lattice of the body wall muscles through a series of mechanical linkages between the muscle cells, the surrounding extracellular matrix, the hypodermis (epidermis), to the collagenous cuticle (the exoskeleton). Mutations in
mua-3 result in a progressive flaccid paralysis of all or part of the body due to detachment of the body wall muscles from the cuticle, thus is apparently required for the normal maintenance of mechanical linkage between muscle and cuticle as the animal grows in size postembryonically. MUA-3 is a novel 3623 amino acid matrix receptor with a large extracellular domain, a single transmembrane helix, and a smaller cytoplasmic domain. The extracellular domain contains four distinct protein-folding motifs, i.e., 5 LDL, 52 EGF, 1 vWFA and 2 SEA modules. These motifs suggest it may help tether the hypodermal cells to the collagenous structures of the basal lamina and/or cuticle. No vertebrate homologs have been identified. A search of GenBank revealed a second C. elegans gene, initially designated
mrp-1, homologous to
mua-3., and a nearly identical C. briggsae ortholog, cbmua-3. It has been subsequently demonstrated by E. Bucher that the
mrp-1 sequence encodes the muscle attachment gene
mup-4 (E. Bucher, personal communication). In order to determine the cellular localization and expression patterns of MUA-3, monoclonal antibodies to the cytoplasmic domain have been raised. Immunofluorecence using anti-MUA-3 antibodies shows localization to the fibrous organelles and other sites where cells form mechanical trans-hypodermal attachments to cuticle. MUA-3 expression is seen in the hypodermis bordering body wall muscle, the ALM and PLM, the rectum, and the vulva. MUA-3 colocalizes with IFA2, encoded by the
mua-6 gene product (see abstract by Hresko et al). The pattern is similar to that reported for MH5 and myotactin, components of the fibrous organelles. Expression is seen as early as the two-fold stage of development. The identification of MUA-3 and MUA-6 as fibrous organelle components suggests that other mua genes may also be involved in fibrous organelle structure, function, or regulation. We are currently examining the localization of MUA-3 in mua mutant strains, looking for informative perturbations, and continuing our efforts to clone additional mua genes to confirm this proposal. Abnormal MUA-3 expression patterns in the
mua-3 mutants
rh195 and
rh169 as well as basement membrane component
unc-52 have been already observed. In addition, genetic and molecular screens to identify other proteins that interact with MUA-3 are in progress.